Network Analysis for Formative Evaluation of Collaborative, Team Science Research Partnerships.

Autor: Liu GM; Department of Human and Organizational Development, Vanderbilt University, Nashville, TN, USA., Meadows ML; Department of Human and Organizational Development, Vanderbilt University, Nashville, TN, USA., Wiley KT; Department of Human and Organizational Development, Vanderbilt University, Nashville, TN, USA., Jurinsky J; Department of Human and Organizational Development, Vanderbilt University, Nashville, TN, USA., Anglemyer AA; Vanderbilt University Medical Center, Vanderbilt Ingram Cancer Center, Nashville, TN, USA., Wang LL; Vanderbilt University Medical Center, Vanderbilt Ingram Cancer Center, Nashville, TN, USA., Schneider JT; Health Information Technology, Vanderbilt University Medical Center, Nashville, TN, USA., Suiter SV; Department of Human and Organizational Development, Vanderbilt University, Nashville, TN, USA.

Publikováno v: Evaluation & the health professions [Eval Health Prof] 2023 Dec; Vol. 46 (4), pp. 334-343. Date of Electronic Publication: 2023 Aug 18.

Improved Prognosis and Increased Tumor-Infiltrating Lymphocytes in Patients Who Have SCLC With Neurologic Paraneoplastic Syndromes.

Autor: Iams WT; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Shiuan E; Vanderbilt University School of Medicine, Nashville, Tennessee., Meador CB; Vanderbilt University School of Medicine, Nashville, Tennessee., Roth M; Vanderbilt University School of Medicine, Nashville, Tennessee., Bordeaux J; Navigate Biopharma Services, Inc., a Novartis Subsidiary, Carlsbad, California., Vaupel C; Navigate Biopharma Services, Inc., a Novartis Subsidiary, Carlsbad, California., Boyd KL; Department of Pathology, Immunology, and Microbiology, Vanderbilt University Medical Center, Nashville, Tennessee., Summitt IB; Navigate Biopharma Services, Inc., a Novartis Subsidiary, Carlsbad, California., Wang LL; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee., Schneider JT; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee., Warner JL; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee., Zhao Z; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee., Lovly CM; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address: christine.lovly@vumc.org.

Publikováno v: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2019 Nov; Vol. 14 (11), pp. 1970-1981. Date of Electronic Publication: 2019 Jun 12.

Rilpivirine analogs potently inhibit drug-resistant HIV-1 mutants.

Autor: Smith SJ; HIV Drug Resistance Program, National Cancer Institute-Frederick, National Institutes of Health, Frederick, MD, USA. smithsj2@mail.nih.gov., Pauly GT; Chemical Biology Laboratory, National Cancer Institute-Frederick, National Institutes of Health, Frederick, MD, USA. paulyg@mail.nih.gov., Akram A; HIV Drug Resistance Program, National Cancer Institute-Frederick, National Institutes of Health, Frederick, MD, USA. aamirakram19@yahoo.com., Melody K; Department of Infectious Diseases and Microbiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA. kpm20@pitt.edu., Rai G; NIH Chemical Genomics Center, National Center for Advancing Translational Sciences, NIH, 9800 Medical Center Drive, Bethesda, MD, 3370, USA. bantukallug@mail.nih.gov., Maloney DJ; NIH Chemical Genomics Center, National Center for Advancing Translational Sciences, NIH, 9800 Medical Center Drive, Bethesda, MD, 3370, USA. maloneyd@mail.nih.gov., Ambrose Z; Department of Infectious Diseases and Microbiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA. zaa4@mail.nih.gov.; Division of Infectious Diseases, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA. zaa4@mail.nih.gov., Thomas CJ; NIH Chemical Genomics Center, National Center for Advancing Translational Sciences, NIH, 9800 Medical Center Drive, Bethesda, MD, 3370, USA. craigt@mail.nih.gov., Schneider JT; Chemical Biology Laboratory, National Cancer Institute-Frederick, National Institutes of Health, Frederick, MD, USA. joel.schneider@mail.nih.gov., Hughes SH; HIV Drug Resistance Program, National Cancer Institute-Frederick, National Institutes of Health, Frederick, MD, USA. hughesst@mail.nih.gov.

Publikováno v: Retrovirology [Retrovirology] 2016 Feb 16; Vol. 13, pp. 11. Date of Electronic Publication: 2016 Feb 16.

Inner-volume imaging in vivo using three-dimensional parallel spatially selective excitation.

Autor: Schneider JT; Bruker BioSpin MRI GmbH, Ettlingen, Germany. Johannes.Schneider@Bruker-BioSpin.de, Kalayciyan R, Haas M, Herrmann SR, Ruhm W, Hennig J, Ullmann P

Publikováno v: Magnetic resonance in medicine [Magn Reson Med] 2013 May; Vol. 69 (5), pp. 1367-78. Date of Electronic Publication: 2012 Jun 21.

BOLD imaging in the mouse brain using a turboCRAZED sequence at high magnetic fields.

Autor: Schneider JT; Department of Experimental Physics 5, University of Würzburg, Würzburg, Germany., Faber C

Publikováno v: Magnetic resonance in medicine [Magn Reson Med] 2008 Oct; Vol. 60 (4), pp. 850-9.